Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.31B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.17B |
| 3 |
Privia Health
PRVA
|
+$1.13B |
| 4 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$1.01B |
| 5 |
Sea Limited
SE
|
+$852M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$960M |
| 2 |
Avantor
AVTR
|
+$895M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$760M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$645M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$640M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.59% |
| 2 | Consumer Discretionary | 9.73% |
| 3 | Financials | 8.55% |
| 4 | Healthcare | 8.03% |
| 5 | Communication Services | 6.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VZIO
3276
PUT
DELISTED
VIZIO Holding Corp.
VZIO
| $5.06M | ﹤0.01% |
+187,500
| New | +$4.41M |
|
3277
ProShares S&P Technology Dividend Aristocrats ETF
TDV
$279M
| $5.05M | ﹤0.01% |
85,298
| – | – |
|
3278
SentinelOne
S
$7.2B
| $5.04M | ﹤0.01% |
+118,626
| New | +$5.04M |
|
3279
CALL
US Bancorp
USB
$100B
| $5.04M | ﹤0.01% |
88,400
+80,800
| +1,063% | +$4.74M |
|
3280
PUT
Devon Energy
DVN
$48.5B
| $5.03M | ﹤0.01% |
172,300
| – | – |
|
|
JBTM
3281
JBT Marel
JBTM
$6.35B
| $5.02M | ﹤0.01% |
35,225
+662
| +2% | +$92.3K |
|
3282
World Kinect Corp
WKC
$1.97B
| $5.02M | ﹤0.01% |
158,276
-95,085
| -38% | -$3.16M |
|
3283
First Internet Bancorp
INBK
$256M
| $5.01M | ﹤0.01% |
161,732
+41,167
| +34% | +$1.4M |
|
|
ESM
3284
DELISTED
ESM Acquisition Corporation
ESM
| $5M | ﹤0.01% |
+518,159
| New | +$5.04M |
|
|
AGEN
3285
Agenus
AGEN
$324M
| $5M | ﹤0.01% |
46,439
-1,850
| -4% | -$139K |
|
|
FLY
3286
DELISTED
Fly Leasing Limited
FLY
| $5M | ﹤0.01% |
295,206
+42,496
| +17% | +$719K |
|
|
3287
Avantor
AVTR
$9.04B
| $5M | ﹤0.01% |
140,682
-27,688,126
| -99% | -$895M |
|
3288
Virtus Biotech Clinical Trials ETF
BBC
$48.6M
| $4.99M | ﹤0.01% |
100,000
| – | – |
|
|
BCPC
3289
Balchem Corp
BCPC
$5.7B
| $4.99M | ﹤0.01% |
37,998
-37,548
| -50% | -$4.83M |
|
3290
Kelly Services Class A
KELYA
$528M
| $4.98M | ﹤0.01% |
207,601
-38,094
| -16% | -$941K |
|
|
LORL
3291
DELISTED
Loral Space and Communications, Inc.
LORL
| $4.97M | ﹤0.01% |
128,026
-24,268
| -16% | -$922K |
|
|
LGACU
3292
DELISTED
Lazard Growth Acquisition Corp. I Units
LGACU
| $4.97M | ﹤0.01% |
497,704
+249,504
| +101% | +$2.5M |
|
|
XRN
3293
Chiron Real Estate Inc
XRN
$464M
| $4.96M | ﹤0.01% |
67,252
+30,638
| +84% | +$2.22M |
|
|
VLDR
3294
PUT
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
| $4.95M | ﹤0.01% |
465,000
-35,000
| -7% | -$413K |
|
3295
Matsons
MATX
$6.22B
| $4.95M | ﹤0.01% |
77,265
+5,457
| +8% | +$356K |
|
|
MDP
3296
DELISTED
Meredith Corporation
MDP
| $4.94M | ﹤0.01% |
113,733
-153,328
| -57% | -$5.44M |
|
|
LFTR
3297
DELISTED
Lefteris Acquisition Corp. Class A Common Stock
LFTR
| $4.92M | ﹤0.01% |
505,099
| – | – |
|
3298
PUT
Illumina
ILMN
$30.2B
| $4.92M | ﹤0.01% |
10,691
-1,131
| -10% | -$456K |
|
3299
Argan
AGX
$8.44B
| $4.92M | ﹤0.01% |
102,870
+86,929
| +545% | +$4.33M |
|
3300
PUT
Alnylam Pharmaceuticals
ALNY
$30.6B
| $4.92M | ﹤0.01% |
29,000
-1,000
| -3% | -$146K |
|
Similar funds
Goldman Sachs's Q2 2021 Portfolio in Review
As of Q2 2021, Goldman Sachs held 6,869 positions worth $446B, up 13% from $396B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Goldman Sachs deployed $20.1B of net new capital in Q2 2021, opening 821 new positions and adding to 2,556 existing holdings. Its largest new stake was Privia Health: 30,513,629 shares worth $1.35B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $960M trimmed.
- Goldman Sachs's largest Q2 2021 buy was Privia Health: 30,513,629 shares worth $1.35B.
- Goldman Sachs added most to Alibaba in Q2 2021, an estimated $1.31B increase.
- Goldman Sachs's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $960M.
- Goldman Sachs fully exited Pluralsight, Inc. Class A Common Stock in Q2 2021, selling an estimated $128M.
- Goldman Sachs's ten largest holdings make up 17% of its $446B portfolio in Q2 2021.
- Goldman Sachs opened 821 new positions and closed 700 in Q2 2021.
- Goldman Sachs's portfolio value rose 13% quarter-over-quarter to $446B.
Based on Goldman Sachs's 13F filing for Q2 2021, filed 13 Aug 2021.